Scholar Rock Holding (STU:2QK) Debt-to-Equity : 0.18 (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Scholar Rock Holding Debt-to-Equity?

Scholar Rock Holding's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was €5.51 Mil. Scholar Rock Holding's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was €56.68 Mil. Scholar Rock Holding's Total Stockholders Equity for the quarter that ended in Dec. 2024 was €352.05 Mil. Scholar Rock Holding's debt to equity for the quarter that ended in Dec. 2024 was 0.18.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Scholar Rock Holding's Debt-to-Equity or its related term are showing as below:

STU:2QK' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.06 Med: 0.18 Max: 0.45
Current: 0.18

During the past 9 years, the highest Debt-to-Equity Ratio of Scholar Rock Holding was 0.45. The lowest was -0.06. And the median was 0.18.

STU:2QK's Debt-to-Equity is ranked worse than
53.25% of 1016 companies
in the Biotechnology industry
Industry Median: 0.14 vs STU:2QK: 0.18

Scholar Rock Holding Debt-to-Equity Historical Data

The historical data trend for Scholar Rock Holding's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scholar Rock Holding Debt-to-Equity Chart

Scholar Rock Holding Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Debt-to-Equity

Get a 7-Day Free Trial

0.22

0.45

0.27

0.18

Scholar Rock Holding Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Debt-to-Equity	Get a 7-Day Free Trial															0.27	0.33	0.51	0.84	0.18

Competitive Comparison of Scholar Rock Holding's Debt-to-Equity

For the Biotechnology subindustry, Scholar Rock Holding's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Scholar Rock Holding's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Scholar Rock Holding's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Scholar Rock Holding's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

Scholar Rock Holding Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Scholar Rock Holding's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(5.514	+	56.681)	/	352.045
	=	0.18

Scholar Rock Holding's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(5.514	+	56.681)	/	352.045
	=	0.18

Scholar Rock Holding (STU:2QK) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Scholar Rock Holding Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Scholar Rock Holding's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Scholar Rock Holding Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scholar Rock Holding Corp (STU:2QK) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

SRRK:USA 2QK:Germany

Address

301 Binney Street, 3rd Floor, Cambridge, MA, USA, 02142

Website

https://www.scholarrock.com

Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.

Scholar Rock Holding Headlines

No Headlines